Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T17:22:09.687Z.
Calculation as of: 2026-10-06T17:22:09.687Z.
Quote observation: 2026-10-06T17:19:58.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 3ba604bfa669edc564cc368ab96d70220aa63ab01e3d3e65254ff63c7dd77471
EARNINGS YIELD
N/A
Market Cap
$139.73M
Earnings Yield
15.11%
TTM Avg
16.11%
3Y Avg
16.11%
5Y Avg
16.11%
Market Cap
$142.56M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$137.11M
Earnings Yield
N/A
TTM Avg
0.17%
3Y Avg
1.25%
5Y Avg
2.17%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immuneering Corporation (IMRX) | $140.67M | N/A | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIOP)vs › | $139.73M | 15.11% | 16.11% | 16.11% | 16.11% |
| Sutro Biopharma, Inc. (STRO)vs › | $142.01M | N/A | N/A | N/A | N/A |
| Protara Therapeutics, Inc. (TARA)vs › | $142.56M | N/A | N/A | N/A | N/A |
| Alpha Cognition Inc (ACOG)vs › | $137.45M | N/A | N/A | N/A | N/A |
| Korsana Biosciences, Inc. (KRSA)vs › | $143.95M | N/A | N/A | N/A | N/A |
| Nyxoah S.A. (NYXH)vs › | $144.10M | N/A | N/A | N/A | N/A |
| KORU Medical Systems, Inc. (KRMD)vs › | $137.11M | N/A | 0.17% | 1.25% | 2.17% |
| Atrium Therapeutics, Inc. (RNA)vs › | $135.82M | N/A | N/A | N/A | N/A |
| Freenome, Inc. (FRNM)vs › | $135.38M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
